Abstract

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), initially characterized as a respiratory pathogen, is now recognized as a systemic vascular and neurotropic disease with profound effects upon the central and peripheral nervous systems. Since 2020, accumulating evidence from neuropathologic investigations, advanced neuroimaging studies, molecular analyses, autopsy series, and longitudinal clinical cohorts has demonstrated that COVID-19 can induce significant motor and sensory dysfunction through complex interactions involving endothelial injury, microvascular thrombosis, neuroinflammation, immune dysregulation, mitochondrial dysfunction, autonomic impairment, and persistent viral antigen exposure.

The resulting neurological syndromes range from transient anosmia and paresthesias to devastating encephalopathy, stroke, myelopathy, movement disorders, peripheral neuropathies, dysautonomia, and chronic motor-sensory impairment associated with Long COVID. Emerging evidence suggests that persistent microvascular dysfunction and neuroimmune activation may continue long after resolution of acute infection, contributing to progressive neurological disability in susceptible individuals.

This review examines the pathophysiological mechanisms by which SARS-CoV-2 affects motor and sensory systems of the brain, emphasizing vascular pathology, neuroimmune responses, neuronal injury, clinical manifestations, diagnostic methodologies, disease progression, therapeutic approaches, rehabilitation strategies, and long-term outcomes. Particular attention is devoted to mechanisms of cortical, subcortical, cerebellar, spinal, and peripheral nervous system injury that ultimately manifest as weakness, sensory loss, impaired coordination, gait instability, and autonomic dysfunction.

Introduction

Few infectious diseases of the modern era have demonstrated the multisystem destructive capacity observed with COVID-19. While the pulmonary manifestations initially dominated clinical attention, neurological complications soon emerged as major contributors to morbidity and mortality.

Within months of the pandemic’s onset, clinicians reported unexpected neurological syndromes including encephalopathy, ischemic stroke, seizures, neuropathies, anosmia, dysautonomia, and profound weakness. Subsequent investigations revealed that the virus does not merely infect the respiratory tract but initiates a systemic inflammatory and vascular cascade capable of affecting virtually every organ system, including the brain.

Neurological manifestations occur across the entire spectrum of disease severity. Individuals with mild respiratory illness may later develop disabling sensory abnormalities, cognitive dysfunction, autonomic instability, or motor impairment. Conversely, critically ill patients may experience extensive cerebrovascular injury, diffuse white matter damage, and long-term neurodegeneration.

The motor-sensory system is particularly vulnerable because it depends upon the integrity of multiple interconnected structures:

Motor cortex
Premotor cortex
Basal ganglia
Thalamus
Cerebellum
Corticospinal tracts
Brainstem nuclei
Spinal cord pathways
Peripheral nerves
Neuromuscular junctions
Skeletal muscle

Disruption at any point along these pathways can result in weakness, sensory deficits, gait abnormalities, tremor, spasticity, dyscoordination, or paralysis.

Neuroanatomical Foundations of Motor-Sensory Function

Understanding COVID-19-associated neurological injury requires appreciation of the architecture of the motor-sensory network.

Motor control originates primarily within the primary motor cortex (M1), located in the precentral gyrus. Signals descend through corticospinal tracts, traverse the internal capsule, pass through the brainstem, and synapse upon anterior horn cells within the spinal cord.

The sensory system follows a complementary pathway. Peripheral receptors transmit information regarding touch, vibration, temperature, proprioception, and pain through ascending spinal tracts to the thalamus and subsequently to the primary somatosensory cortex.

Normal movement requires exquisite coordination among:

Cortical motor planning centers
Cerebellar feedback circuits
Basal ganglia modulation
Peripheral sensory input
Autonomic regulation
Microvascular perfusion

Disruption of any component may produce measurable motor-sensory dysfunction.

COVID-19 has demonstrated the capacity to affect all of these structures simultaneously.

Mechanisms of SARS-CoV-2 Neuroinvasion

The precise mechanism through which SARS-CoV-2 affects neural tissues remains incompletely understood.

Current evidence suggests multiple overlapping pathways.

Direct Neural Invasion

Neurons and glial cells express varying levels of ACE2 receptors, neuropilin-1 receptors, and other molecular targets facilitating viral interaction.

Studies have demonstrated viral RNA and viral proteins within:

Olfactory epithelium
Brainstem structures
Cranial nerves
Cortical tissues

However, direct viral invasion appears less common than initially proposed.

Rather than widespread neuronal infection, current evidence favors indirect mechanisms of injury mediated through vascular and immune pathways.

Olfactory Route

One of the earliest recognized neurological manifestations was anosmia.

The olfactory epithelium represents a potential portal of entry into the nervous system.

Damage to:

Sustentacular cells
Olfactory sensory neurons
Supporting microvascular structures

may permit inflammatory signals and viral components to reach the olfactory bulb.

Neuroimaging studies have demonstrated alterations within:

Olfactory bulbs
Orbitofrontal cortex
Limbic regions

suggesting transneuronal propagation of inflammatory injury.

Hematogenous Spread

Systemic viremia enables viral particles, inflammatory cytokines, and activated immune cells to interact with the cerebral vasculature.

The blood-brain barrier (BBB), normally a tightly regulated protective structure, becomes compromised during systemic inflammation.

Elevated concentrations of:

IL-6
TNF-α
IL-1β
Interferon-associated mediators

increase endothelial permeability and facilitate neuroinflammatory injury.

Endothelial Injury and Microvascular Pathology

Perhaps the most important neurological discovery of the COVID era has been recognition that SARS-CoV-2 is fundamentally a vascular disease.

Endothelial cells lining cerebral blood vessels become dysfunctional through direct and indirect mechanisms.

Autopsy studies consistently demonstrate:

Endotheliitis
Perivascular inflammation
Capillary rarefaction
Microthrombi
Fibrin deposition

These abnormalities produce widespread disturbances in cerebral perfusion.

Endotheliopathy

Healthy endothelial cells regulate:

Blood flow
Coagulation
Inflammation
Vascular permeability

SARS-CoV-2 disrupts all four functions.

Injured endothelial cells exhibit:

Reduced nitric oxide production
Increased oxidative stress
Increased platelet activation
Increased coagulation signaling

The result is a prothrombotic state affecting cerebral circulation.

Microthrombi Formation

Autopsy investigations have revealed innumerable microscopic thrombi throughout cerebral capillary networks.

Unlike large-vessel strokes, these microvascular obstructions often evade conventional neuroimaging.

Nevertheless, their cumulative effects may be profound.

Consequences include:

Focal ischemia
Axonal injury
Demyelination
Neuronal death

Motor pathways appear particularly vulnerable because of their substantial metabolic requirements.

Capillary Dysfunction

Even without complete occlusion, microvascular abnormalities may impair oxygen delivery.

Neurons require continuous aerobic metabolism.

Subtle reductions in oxygen availability can disrupt:

Synaptic transmission
Action potential propagation
Neurotransmitter synthesis

These disturbances may manifest clinically as:

Weakness
Fatigue
Reduced coordination
Slowed movement
Sensory abnormalities

Neuroinflammation and Motor-Sensory Injury

The immune response to SARS-CoV-2 often exceeds the direct effects of viral replication.

Activation of innate and adaptive immune pathways generates widespread inflammation within the nervous system.

Microglia become activated and assume a pro-inflammatory phenotype.

These cells release:

IL-1β
IL-6
TNF-α
Reactive oxygen species

Chronic activation can produce secondary neuronal injury.

Microglial Activation

Neuropathological studies have demonstrated extensive microglial nodules throughout:

Brainstem
White matter
Cortex
Basal ganglia

Persistent activation may contribute to long-term neurological symptoms.

Activated microglia impair:

Synaptic plasticity
Axonal repair
Neurogenesis

These effects may underlie chronic motor deficits observed in Long COVID.

Astrocyte Dysfunction

Astrocytes regulate neuronal metabolism and maintain blood-brain barrier integrity.

COVID-associated inflammation disrupts astrocytic function.

Consequences include:

Impaired glutamate clearance
Excitotoxicity
Metabolic instability
Reduced neuronal support

Motor neurons are particularly susceptible to these disturbances.

White Matter Injury

White matter serves as the communication network of the brain.

Numerous MRI studies have demonstrated abnormalities involving:

Corpus callosum
Internal capsule
Corona radiata
Corticospinal tracts

Diffusion tensor imaging reveals alterations consistent with axonal injury and demyelination.

Because corticospinal tracts mediate voluntary movement, white matter injury frequently manifests as motor dysfunction.

Clinical findings may include:

Weakness
Gait instability
Hyperreflexia
Spasticity

Basal Ganglia Involvement

The basal ganglia play a central role in movement initiation and control.

COVID-related injury within these structures may produce:

Bradykinesia
Tremor
Rigidity
Dystonia

Several reports have described Parkinsonian syndromes emerging after SARS-CoV-2 infection.

Potential mechanisms include:

Neuroinflammation
Microvascular ischemia
Dopaminergic pathway injury

Although uncommon, these observations raise concern regarding accelerated neurodegenerative processes.

Cerebellar Injury

The cerebellum coordinates movement precision.

COVID-associated cerebellar injury may result from:

Microvascular ischemia
Autoimmune responses
Inflammatory demyelination

Clinical manifestations include:

Ataxia
Dysmetria
Balance impairment
Gait instability

Longitudinal studies suggest some patients experience persistent cerebellar dysfunction for years following infection.

Sensory Pathway Dysfunction

Sensory abnormalities represent among the most common neurological sequelae.

Patients frequently report:

Numbness
Tingling
Burning pain
Altered temperature sensation
Loss of proprioception

Potential mechanisms include:

Small-fiber neuropathy
Thalamic dysfunction
Cortical sensory injury
Microvascular ischemia

Small-fiber neuropathy has emerged as a particularly important contributor to Long COVID sensory symptoms.

Skin biopsies frequently reveal reduced intraepidermal nerve fiber density, supporting a structural basis for persistent sensory complaints.

Early Clinical Manifestations of Motor-Sensory Injury

Motor-sensory dysfunction may emerge during acute infection or months later.

Common manifestations include:

Motor Symptoms

Generalized weakness
Proximal muscle weakness
Difficulty arising from a chair
Gait instability
Tremor
Coordination impairment
Falls
Exercise intolerance

Sensory Symptoms

Numbness
Paresthesias
Neuropathic pain
Burning feet
Altered vibration sensation
Proprioceptive loss

Combined Motor-Sensory Syndromes

Ataxic gait
Balance impairment
Postural instability
Dysautonomia-associated weakness

These symptoms frequently coexist with cognitive dysfunction and autonomic abnormalities.

Part II: Cerebrovascular Injury, Corticospinal Tract Pathology, Spinal Cord Disease, Peripheral Neuropathy, Dysautonomia, Clinical Evaluation, and Diagnostic Methodologies

Cerebrovascular Disease as a Primary Mechanism of Motor-Sensory Injury

As understanding of COVID-19 evolved, it became increasingly apparent that many neurological manifestations could not be explained solely by direct viral effects or inflammatory cytokines. Rather, the disease appeared capable of inducing a profound vasculopathy affecting arteries, arterioles, capillaries, venules, and veins throughout the central nervous system.

The brain is extraordinarily dependent upon uninterrupted blood flow. Although constituting approximately 2% of total body mass, it consumes nearly 20% of resting oxygen utilization and approximately 25% of glucose metabolism. Consequently, even brief interruptions in cerebral perfusion can produce neuronal dysfunction.

COVID-19 creates a unique environment characterized by:

Hypercoagulability
Endothelial dysfunction
Platelet activation
Complement activation
Inflammatory vasculopathy
Impaired fibrinolysis

Together these processes establish conditions favorable for both large-vessel and microvascular ischemic injury.

Large Vessel Stroke

One of the earliest alarming observations during the pandemic was the occurrence of ischemic stroke among relatively young patients without traditional cerebrovascular risk factors.

Multiple studies subsequently demonstrated substantially elevated risks of ischemic stroke during acute SARS-CoV-2 infection.

Mechanisms include:

Endothelial Activation

Endothelial cells become highly prothrombotic following exposure to inflammatory mediators.

Expression increases for:

Tissue factor
Von Willebrand factor
P-selectin
Adhesion molecules

These alterations promote clot formation within cerebral arteries.

Hypercoagulability

COVID-associated coagulopathy differs from conventional disseminated intravascular coagulation.

Affected patients frequently exhibit:

Elevated D-dimer
Elevated fibrinogen
Increased factor VIII
Increased platelet aggregation

These abnormalities significantly increase thrombotic risk.

Cardioembolism

COVID-related cardiac injury may contribute to stroke through:

Atrial fibrillation
Myocarditis
Ventricular dysfunction
Intracardiac thrombus formation

The resulting emboli may occlude major cerebral vessels.

Clinical Consequences of Stroke

Motor deficits depend upon the vascular territory involved.

Middle cerebral artery infarctions frequently produce:

Contralateral hemiparesis
Facial weakness
Sensory deficits
Aphasia

Anterior cerebral artery involvement may cause:

Leg-predominant weakness
Gait disturbances
Executive dysfunction

Posterior circulation strokes may result in:

Ataxia
Dysarthria
Vertigo
Cranial nerve deficits

Because many COVID-associated strokes occur within a background of systemic inflammation, outcomes are often more severe than expected from infarct size alone.

Silent Cerebral Infarction

An emerging concern involves silent ischemic injury.

Advanced MRI studies have identified evidence of:

Microinfarcts
White matter ischemia
Diffuse vascular injury

even among individuals who never experienced overt stroke symptoms.

These lesions may accumulate over time and contribute to:

Cognitive decline
Impaired gait
Sensory abnormalities
Reduced motor coordination

The true long-term burden of these silent injuries remains unknown.

Corticospinal Tract Injury

The corticospinal tract represents the principal pathway through which voluntary movement is transmitted from the cerebral cortex to the spinal cord.

Because these fibers traverse long distances through highly vascularized white matter regions, they are especially susceptible to ischemic and inflammatory injury.

Neuropathological investigations have demonstrated:

Axonal swelling
Myelin disruption
Microvascular injury
Perivascular inflammation

within motor pathways.

Consequences of Corticospinal Dysfunction

Damage to upper motor neuron pathways may produce:

Early Symptoms

Leg heaviness
Difficulty climbing stairs
Slowed movement
Fatigability

Progressive Symptoms

Hyperreflexia
Spasticity
Gait impairment
Balance abnormalities

Advanced Manifestations

Severe weakness
Contractures
Functional dependence

Many Long COVID patients describe sensations of “disconnect” between intention and movement, suggesting disruption of motor signaling networks rather than primary muscle disease alone.

White Matter Network Failure

Movement depends upon coordinated communication among distributed brain regions.

Modern neuroimaging studies have demonstrated abnormalities involving:

Superior longitudinal fasciculus
Corpus callosum
Internal capsule
Corona radiata

These structures serve as information highways linking motor and sensory systems.

Diffusion tensor imaging studies frequently reveal reduced fractional anisotropy, suggesting:

Axonal injury
Demyelination
Neuroinflammatory damage

Disruption of these networks may contribute to:

Brain fog
Motor slowing
Coordination deficits
Impaired proprioception

Spinal Cord Pathology

Although less common than cerebral involvement, spinal cord injury represents an important source of motor-sensory dysfunction.

Several mechanisms have been proposed.

Acute Transverse Myelitis

Transverse myelitis has been reported following both acute COVID infection and post-infectious immune activation.

Pathological features include:

Inflammatory infiltration
Demyelination
Axonal injury
Edema

Symptoms may develop rapidly over hours or days.

Clinical manifestations include:

Weakness
Sensory loss
Bowel dysfunction
Bladder dysfunction
Gait impairment

MRI frequently demonstrates longitudinally extensive lesions.

Immune-Mediated Myelopathy

Autoimmune mechanisms appear particularly important.

Molecular mimicry may result in immune responses directed against neural antigens.

Potential targets include:

Myelin proteins
Axonal components
Astrocytic structures

Persistent inflammation can produce chronic neurological deficits.

Microvascular Injury of the Spinal Cord

The spinal cord possesses an extensive microvascular network that is vulnerable to endothelial dysfunction.

Autopsy investigations suggest:

Capillary injury
Small vessel thrombosis
Perivascular inflammation

may contribute to motor-sensory deficits even in the absence of overt myelitis.

Peripheral Nervous System Injury

A substantial proportion of neurological symptoms arise from damage outside the brain itself.

Peripheral nerves may be injured through:

Immune-mediated mechanisms
Microvascular dysfunction
Persistent inflammation
Autoantibody production

Small Fiber Neuropathy

Small fiber neuropathy has emerged as one of the most common neurological findings in Long COVID.

Affected fibers regulate:

Pain sensation
Temperature sensation
Autonomic function

Clinical symptoms include:

Burning feet
Tingling
Electric shock sensations
Temperature intolerance
Allodynia

Skin biopsy frequently demonstrates reduced nerve fiber density.

Large Fiber Neuropathy

Larger sensory and motor fibers may also be affected.

Symptoms include:

Sensory Findings

Numbness
Loss of vibration sensation
Impaired proprioception

Motor Findings

Weakness
Reduced reflexes
Muscle wasting

Such deficits may significantly impair mobility and balance.

Guillain-Barré Syndrome

Guillain-Barré syndrome (GBS) remains among the best-characterized post-infectious neuropathies associated with COVID-19.

This immune-mediated disorder results from antibody attack upon peripheral nerves.

Clinical progression often follows a characteristic pattern:

Distal paresthesias
Ascending weakness
Loss of reflexes
Respiratory compromise (severe cases)

Prompt recognition is critical because treatment may substantially improve outcomes.

Dysautonomia and Motor-Sensory Function

One of the most intriguing aspects of Long COVID is the prevalence of autonomic dysfunction.

The autonomic nervous system regulates:

Heart rate
Blood pressure
Gastrointestinal function
Temperature regulation
Cerebral blood flow

Disruption can profoundly affect motor performance.

Postural Orthostatic Tachycardia Syndrome (POTS)

POTS has become one of the most frequently reported dysautonomic syndromes following COVID.

Patients commonly experience:

Tachycardia
Dizziness
Weakness
Exercise intolerance
Cognitive dysfunction

Reduced cerebral perfusion may impair motor performance despite preserved muscle strength.

Neurovascular Dysregulation

Emerging evidence suggests impaired regulation of cerebral blood flow contributes significantly to Long COVID symptoms.

Mechanisms include:

Endothelial dysfunction
Autonomic imbalance
Impaired vasodilation
Microvascular injury

Patients often report dramatic worsening of symptoms during standing or exertion.

Mitochondrial Dysfunction and Motor Fatigue

Movement requires enormous quantities of cellular energy.

Recent studies suggest SARS-CoV-2 may induce abnormalities involving:

Oxidative phosphorylation
ATP production
Mitochondrial signaling

These disturbances may contribute to profound motor fatigue observed in Long COVID.

Patients frequently describe:

Heavy legs
Muscle exhaustion
Post-exertional worsening
Delayed recovery

Such symptoms often occur despite normal conventional neurological examination findings.

Clinical Evaluation of Motor-Sensory Dysfunction

Comprehensive assessment requires detailed history and examination.

Important historical questions include:

Motor Symptoms

Difficulty standing
Stair climbing ability
Falls
Gait changes
Tremor

Sensory Symptoms

Numbness
Burning pain
Tingling
Proprioceptive abnormalities

Autonomic Symptoms

Orthostatic dizziness
Palpitations
Temperature intolerance
Gastrointestinal dysmotility

Neurological Examination

A thorough examination should assess:

Cranial Nerves

Evaluation of:

Eye movements
Facial sensation
Facial strength
Hearing
Swallowing

Motor Function

Assessment includes:

Muscle bulk
Tone
Strength
Coordination

Reflexes

Abnormalities may localize pathology to:

Central nervous system
Peripheral nervous system
Neuromuscular junction

Sensory Testing

Evaluation should include:

Light touch
Pinprick
Temperature
Vibration
Proprioception

Neuroimaging

MRI remains the cornerstone of structural assessment.

Important sequences include:

T1-weighted imaging
T2-weighted imaging
FLAIR imaging
Diffusion-weighted imaging
Susceptibility-weighted imaging

These studies may identify:

Infarction
Demyelination
Microhemorrhage
White matter abnormalities

Advanced Imaging

Advanced modalities increasingly reveal abnormalities not visible on conventional MRI.

These include:

Diffusion Tensor Imaging

Detects:

Axonal injury
White matter disruption

Functional MRI

Assesses:

Connectivity
Network dysfunction

PET Imaging

Evaluates:

Neuroinflammation
Metabolic abnormalities

Electrophysiological Studies

Electrophysiological testing frequently provides objective evidence of dysfunction.

These studies include:

Nerve Conduction Studies

Evaluate:

Large fiber neuropathy
Demyelination

Electromyography

Assesses:

Motor unit integrity
Muscle involvement

Quantitative Sensory Testing

Measures:

Small fiber function
Sensory thresholds

Autonomic Testing

Includes:

Tilt-table testing
Heart rate variability analysis
Sudomotor testing

Biomarkers of Neurological Injury

Numerous biomarkers are under investigation.

Potential markers include:

Neurofilament light chain
GFAP
Tau protein
Cytokine profiles
Endothelial markers

These biomarkers may eventually facilitate earlier diagnosis and prognostication.

Part III: Neuroimmune Mechanisms, Persistent Neuroinflammation, Neurodegeneration, Therapeutic Management, Rehabilitation, Recovery Trajectories, and Long-Term Outcomes

Neuroimmune Dysregulation as a Driver of Persistent Motor–Sensory Dysfunction

As the pandemic progressed, clinicians observed a striking phenomenon. Many patients who survived the acute infection continued to experience neurological symptoms months or even years later. These individuals frequently demonstrated little evidence of active viral replication, yet their symptoms persisted.

This observation shifted scientific attention toward the possibility that COVID-19 initiates a prolonged neuroimmune disorder characterized by persistent inflammation, immune dysregulation, endothelial dysfunction, and altered neural repair mechanisms.

Current evidence increasingly suggests that many long-term neurological manifestations arise not from direct viral cytotoxicity but from sustained activation of immune pathways that continue long after acute infection has resolved.

Persistent Microglial Activation

Microglia serve as the resident immune cells of the central nervous system.

Under physiological conditions they:

Remove debris
Eliminate damaged neurons
Support synaptic remodeling
Maintain neural homeostasis

During COVID-19, however, microglia may become chronically activated.

Neuropathological studies have demonstrated:

Activated microglial nodules
Increased inflammatory cytokines
Perivascular immune aggregates
White matter inflammatory infiltrates

throughout multiple brain regions.

Particularly affected structures include:

Brainstem
Thalamus
Basal ganglia
Cerebellum
Frontal cortex

Persistent activation may impair neural recovery and contribute to chronic motor-sensory dysfunction.

Cytokine-Mediated Neuronal Injury

Many investigators now believe that cytokine exposure represents a major mechanism of neurological injury.

Inflammatory mediators include:

Interleukin-1β
Interleukin-6
Tumor necrosis factor-alpha
Interferon-gamma

These molecules exert widespread effects upon neural tissues.

Consequences include:

Altered neurotransmission
Impaired synaptic plasticity
Reduced neurogenesis
Mitochondrial dysfunction
Oxidative stress

Motor pathways appear especially vulnerable because of their substantial metabolic requirements.

Autoimmunity and Molecular Mimicry

An increasingly compelling hypothesis proposes that SARS-CoV-2 may trigger autoimmune responses directed against neural structures.

Molecular mimicry occurs when viral proteins resemble host antigens.

The immune system may subsequently generate antibodies that attack:

Neurons
Myelin
Endothelial cells
Autonomic ganglia
Peripheral nerves

Numerous autoantibodies have been identified in COVID-19 patients.

Potential targets include:

Gangliosides
Adrenergic receptors
Muscarinic receptors
Phospholipids
Endothelial proteins

These autoimmune phenomena may explain persistent symptoms despite clearance of active infection.

Persistent Viral Antigens and Reservoir Hypotheses

One of the most actively investigated areas concerns persistence of viral material.

Several studies have identified SARS-CoV-2 proteins and RNA fragments months after acute infection within:

Gastrointestinal tissues
Lymphatic tissues
Vascular tissues
Neural tissues

The implications remain uncertain.

Even if replication-competent virus is absent, residual viral proteins may continue stimulating immune responses.

This persistent antigen exposure could contribute to:

Chronic inflammation
Endothelial activation
Microglial stimulation
Autonomic dysfunction

Blood–Brain Barrier Dysfunction

The blood-brain barrier represents a highly specialized interface separating circulating blood from neural tissue.

Healthy BBB function depends upon:

Endothelial integrity
Tight junctions
Astrocyte support
Pericyte regulation

COVID-associated inflammation disrupts these structures.

Consequences include:

Increased permeability
Immune cell infiltration
Protein leakage
Neuroinflammation

Persistent BBB dysfunction may allow chronic exposure of neural tissues to inflammatory mediators.

Neurotransmitter Disturbances

Motor and sensory function depend upon balanced neurotransmitter activity.

Evidence suggests COVID may affect:

Dopamine

Important for:

Movement initiation
Motivation
Motor coordination

Disruption may contribute to:

Bradykinesia
Fatigue
Parkinsonian features

Acetylcholine

Essential for:

Neuromuscular transmission
Autonomic regulation
Cognitive processing

Abnormalities may worsen dysautonomia and weakness.

Serotonin

Involved in:

Sensory processing
Pain modulation
Mood regulation

Dysregulation may contribute to chronic sensory symptoms.

Mitochondrial Injury and Energy Failure

Among the most significant discoveries in Long COVID research is evidence of mitochondrial dysfunction.

Neurons possess extraordinary energy demands.

Normal function requires continuous ATP generation.

COVID-associated abnormalities include:

Impaired oxidative phosphorylation
Altered mitochondrial morphology
Increased reactive oxygen species
Reduced ATP production

Motor neurons appear particularly susceptible.

Consequences may include:

Weakness
Motor fatigue
Exercise intolerance
Delayed recovery after exertion

Many patients describe symptoms resembling metabolic exhaustion rather than conventional muscle weakness.

Neurodegenerative Implications

A major unresolved question concerns whether COVID accelerates neurodegenerative disease.

Several mechanisms raise concern.

Protein Misfolding

Inflammatory conditions may promote accumulation of abnormal proteins including:

Tau
Alpha-synuclein
Amyloid-beta

These proteins play central roles in disorders such as:

Alzheimer’s disease
Parkinson’s disease
Lewy body disease

Although causality remains unproven, investigators continue monitoring survivors for evidence of accelerated neurodegeneration.

Chronic Neuroinflammation

Persistent inflammation is recognized as a risk factor for neurodegenerative disease.

Microglial activation may contribute to:

Synaptic loss
Axonal degeneration
Progressive neuronal dysfunction

Long-term surveillance studies remain ongoing.

White Matter Aging

Several neuroimaging investigations suggest COVID survivors exhibit structural changes resembling accelerated brain aging.

Reported findings include:

Reduced cortical thickness
White matter abnormalities
Connectivity disturbances

Whether these findings represent reversible injury or permanent damage remains uncertain.

Functional Impact of Motor–Sensory Dysfunction

The ultimate clinical significance of neurological injury lies in its effect upon daily functioning.

Patients frequently experience profound limitations despite relatively modest findings on conventional imaging.

Common impairments include:

Mobility

Difficulty walking
Reduced endurance
Balance impairment
Increased falls

Activities of Daily Living

Rising from chairs
Climbing stairs
Bathing
Dressing

Occupational Function

Reduced productivity
Early retirement
Disability

Social Function

Reduced participation
Isolation
Loss of independence

Clinical Progression

Motor-sensory symptoms may follow several trajectories.

Recovery Pattern

Some patients experience gradual improvement over months.

Mechanisms may include:

Resolution of inflammation
Neuroplasticity
Vascular recovery

These individuals often regain substantial function.

Persistent Stable Dysfunction

Many patients plateau with residual deficits.

Symptoms may remain relatively unchanged for years.

Common examples include:

Neuropathy
Dysautonomia
Mild weakness
Sensory loss

Progressive Course

A smaller subset reports worsening symptoms.

Potential mechanisms include:

Ongoing immune activation
Progressive vascular dysfunction
Secondary deconditioning
Neurodegenerative processes

Further investigation is required.

Diagnostic Monitoring

Longitudinal evaluation should include:

Neurological Examination

Monitoring:

Strength
Reflexes
Coordination
Sensory function

Functional Assessment

Measurement of:

Walking distance
Gait speed
Balance

Neuropsychological Testing

Assessment of:

Executive function
Attention
Processing speed

Imaging

Serial MRI may identify:

White matter progression
Vascular injury
Structural recovery

Therapeutic Management

At present no single therapy reverses COVID-related neurological injury.

Management therefore focuses upon:

Treating active pathology
Supporting recovery
Preventing secondary complications

Anti-Inflammatory Strategies

Various approaches have been investigated.

These include:

Corticosteroids
Intravenous immunoglobulin
Plasmapheresis
Cytokine-targeting therapies

Evidence remains strongest for selected immune-mediated syndromes such as:

Guillain-Barré syndrome
Autoimmune encephalitis
Myelitis

Antithrombotic Approaches

Because vascular injury plays a central role, antithrombotic strategies have received substantial attention.

Potential interventions include:

Antiplatelet therapy
Anticoagulation
Endothelial stabilization

Optimal approaches remain under investigation.

Dysautonomia Management

Treatment often includes:

Non-Pharmacologic Measures

Increased fluid intake
Salt supplementation
Compression garments
Physical conditioning

Pharmacologic Therapies

Depending upon symptoms:

Fludrocortisone
Midodrine
Beta blockers
Pyridostigmine

Individualized treatment is essential.

Neuropathic Pain Management

Commonly utilized therapies include:

Gabapentin
Pregabalin
Duloxetine
Tricyclic antidepressants

Pain management frequently requires multidisciplinary care.

Neurorehabilitation

Rehabilitation remains among the most important therapeutic interventions.

Physical Therapy

Goals include:

Strength restoration
Balance training
Gait improvement

Programs must be individualized because excessive exertion may worsen symptoms in susceptible patients.

Occupational Therapy

Focuses upon:

Functional independence
Energy conservation
Adaptive strategies

Vestibular Rehabilitation

Beneficial for patients experiencing:

Dizziness
Disequilibrium
Gait instability

Cognitive Rehabilitation

Addresses:

Brain fog
Executive dysfunction
Attention deficits

These interventions may indirectly improve motor performance.

Neuroplasticity and Recovery

The nervous system possesses remarkable capacity for adaptation.

Recovery mechanisms include:

Synaptic remodeling
Axonal sprouting
Functional reorganization

Rehabilitation seeks to harness these processes.

However, persistent inflammation may interfere with neural repair, highlighting the importance of identifying and treating ongoing pathological mechanisms.

Long-Term Outcomes

Longitudinal studies reveal substantial heterogeneity.

Some individuals recover completely.

Others experience chronic disability extending years beyond infection.

Persistent symptoms commonly include:

Weakness
Sensory abnormalities
Exercise intolerance
Dysautonomia
Cognitive impairment

Functional outcomes appear influenced by:

Age
Severity of acute illness
Comorbid disease
Degree of vascular injury
Immune response characteristics

Future Directions

Major unanswered questions remain.

Critical priorities include:

Identification of reliable biomarkers.
Determination of mechanisms driving persistent neuroinflammation.
Clarification of viral persistence hypotheses.
Development of targeted immunotherapies.
Optimization of rehabilitation strategies.
Long-term surveillance for neurodegenerative outcomes.
Prevention of chronic neurological disability.

The next decade will likely witness substantial advances in understanding the relationship between SARS-CoV-2 infection and chronic neurological disease.

Conclusion

COVID-19 has fundamentally altered contemporary understanding of viral neurological disease. What began as a respiratory pandemic has evolved into recognition of a complex neurovascular and neuroimmunological disorder capable of producing widespread motor-sensory dysfunction. Through endothelial injury, microvascular thrombosis, neuroinflammation, mitochondrial dysfunction, autoimmune responses, autonomic dysregulation, and possible persistent antigen exposure, SARS-CoV-2 can disrupt virtually every level of the motor-sensory neuraxis.

The consequences range from transient paresthesias to profound weakness, gait impairment, sensory loss, dysautonomia, and long-term disability. Although substantial progress has been made in characterizing these mechanisms, many questions remain regarding persistence, reversibility, and the potential for accelerated neurodegeneration. Continued multidisciplinary investigation will be essential to define optimal therapeutic strategies and improve outcomes for the growing population of individuals living with the neurological sequelae of COVID-19

References

Meinhardt J, et al. Olfactory transmucosal SARS-CoV-2 invasion as a route to central nervous system entry. Nature Neuroscience. 2021.
Matschke J, et al. Neuropathology of patients with COVID-19 in Germany. Lancet Neurology. 2020.
Lee MH, et al. Microvascular injury in the brains of patients with COVID-19. New England Journal of Medicine. 2021.
Thakur KT, et al. COVID-19 neuropathology at Columbia University. Brain. 2021.
Zlokovic BV. Neurovascular pathways to neurodegeneration. Nature Reviews Neuroscience. 2011.
Taquet M, et al. Neurological and psychiatric risk trajectories after COVID-19. Lancet Psychiatry. 2022.
Douaud G, et al. SARS-CoV-2 associated structural brain changes. Nature. 2022.
Becker JH, et al. Long COVID and neurological sequelae. Nature Reviews Neurology. 2023.
Iadecola C, et al. COVID-19 and the nervous system. Neuron. 2020.
Heneka MT, et al. Immediate and long-term consequences of CO
Oxley TJ, et al. Large-vessel stroke as a presenting feature of COVID-19. New England Journal of Medicine. 2020.
Nannoni S, et al. Stroke in COVID-19: epidemiology and pathophysiology. International Journal of Stroke. 2021.
Paterson RW, et al. The emerging spectrum of COVID-19 neurology. Brain. 2020.
Zubair AS, et al. Neuropathogenesis and neurologic manifestations of COVID-19. JAMA Neurology. 2020.
Koralnik IJ, Tyler KL. COVID-19 and the nervous system. JAMA. 2020.
Novak P, et al. Multisystem involvement in post-acute sequelae of COVID-19. Neurology. 2022.
Oaklander AL, et al. Peripheral neuropathy evaluations in Long COVID. Neurology Neuroimmunology & Neuroinflammation. 2022.
Dani M, et al. Autonomic dysfunction in Long COVID. Clinical Medicine. 2021.
Nath A. Long COVID and neurological sequelae. Nature Reviews Neurology. 2024.
Davis HE, et al. Characterizing Long COVID in an international cohort. EClinicalMedicine. 2021.
Heneka MT, et al. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer’s Research & Therapy. 2020.
Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19. Nature Reviews Microbiology. 2024.
Fernández-Castañeda A, et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022.
Choutka J, et al. Unexplained post-acute infection syndromes. Nature Medicine. 2022.
Iwasaki A, Putrino D. Why we need a deeper understanding of Long COVID. Lancet Infectious Diseases. 2023.
Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of Long COVID. Trends in Immunology. 2022.
Frontera JA, et al. Neurological events and outcomes in hospitalized COVID patients. Neurology. 2021.
Nalbandian A, et al. Post-acute COVID syndrome. Nature Medicine. 2021.
Stein SR, et al. SARS-CoV-2 infection and persistence throughout the human body and brain. Nature. 2022.
Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings and future directions. Nature Reviews Microbiology. 2023.